Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Pharmaceutical Executive February 1, 2007 Sarah Houlton	Global Report: Under One Roof The UK government is planning to set up a single body to oversee all health research in universities and hospitals - and to facilitate partnerships between government agencies and industry.
Pharmaceutical Executive December 1, 2011	UK Report: Keep Calm and Carry On ... Differently Even as the global economic roller coaster affects one of the country's dearest public institutions, the National Health Service, there is still reason for optimism in these times of austerity.
Pharmaceutical Executive December 1, 2006 Sarah Houlton	Global Report: Not So NICE A new manifesto by the Association of the British Pharmaceutical Industry is designed to improve drug access in the UK, where industry has worried for years about poor uptake of new medicines.
Chemistry World March 14, 2013 Maria Burke	MPs call for a bridge over 'valley of death' A lack of government support is letting down UK small technology entrepreneurs, MPs warn in a new report. They call for a 'coherent' government strategy to help businesses bridge the gap between concept and commercialization, dubbed the 'valley of death'.
Pharmaceutical Executive May 1, 2012	Value-Based Pricing: Too High a Price for UK Pharma? Changes to the system in the UK could finally put some real metrics behind the elusive concept of value but with payers clearly in the driver's seat, who needs clarity?
Pharmaceutical Executive April 1, 2012 Feam & Lagus	Providing Access Now While regulatory frameworks and medical practices differ between countries, many patients still need early access to new drugs. Industry can help.
Chemistry World March 17, 2014 Phillip Broadwith	UK to fast-track access to critical medicines Critically ill patients in the UK could receive new medicines before they are formally approved under a new scheme beginning in April.
Pharmaceutical Executive August 1, 2008 Sarah Houlton	Jumping the Gun The Association of the British Pharmaceutical Industry and the British government have come up with a solution for price regulation that isn't as bad as the industry had feared.
Pharmaceutical Executive May 1, 2005 Sarah Houlton	Global Report: Iron Fist The United Kingdom is hardening its stance on pharma industry issues.
Chemistry World October 17, 2012 Maria Burke	GSK pledge on trials transparency GlaxoSmithKline has announced a series of initiatives to make clinical trial data publically available that could set a precedent in an industry not known for its transparency.
CIO October 1, 2005 Montalbano & Niccolai	England's New Patient Record System Ailing A study in the British Medical Journal reports that an effort in England to centralize patient records on a standard IT system is at risk because local staff are feeling left out of the implementation process.
Chemistry World April 23, 2013 Emma Stoye	Invest in research or be left behind, UK academies warn The UK's four national academies have called on the government to increase investment in research over the next decade or risk being overtaken by international competitors.
Chemistry World July 2010	Meeting Mr NICE guy Bibiana Campos-Seijo meets the chief executive of the National Institute for Health and Clinical Excellence, Sir Andrew Dillon
Chemistry World June 18, 2008 Ananyo Bhattacharya	Deal on NHS drugs set to trim pharma profits An agreement between the UK government and the pharmaceutical industry will cut around five per cent off the cost of medicines sold to the National Health Service
Pharmaceutical Executive April 1, 2012 Ben Comer	Divided Kingdom What does a Scottish vote for independence mean for Big Pharma investment and healthcare funding and delivery in the UK?
Chemistry World March 22, 2012 Andrew Turley	GSK to build 350 million factory in UK GlaxoSmithKline has announced plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria.
Chemistry World October 5, 2007 Ananyo Bhattacharya	UK Government Expected to Strengthen Science The UK government is to launch a 'major campaign' to strengthen school science and overhaul its own science and technology investment.
Chemistry World March 4, 2013 Andy Extance	UK considers patent rule change for trials The UK has announced plans to amend aspects of its patent law that may be encouraging pharma companies to run their clinical trials in other countries.
Pharmaceutical Executive October 1, 2008 Sarah Houlton	Open For Debate Tensions mount as stakeholders in the UK health industry attempt to work out drug cost problems.
Chemistry World April 21, 2009 Matt Wilkinson	Survival of the fittest While the pharmaceutical and biopharmaceutical sectors in general are outperforming broader stock market trends, many early stage companies are desperately trying to conserve cash and raise money to keep going.
Pharmaceutical Executive September 1, 2011 Richard Barker	Innovating Around Innovation The former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.
Pharmaceutical Executive May 1, 2011 Julian Upton	UK Stakeholders Have Their Say on Value-Based Pricing The UK coalition government's consultation on the intro of value-based pricing has invited caution and resistance.
Chemistry World March 2009 James Mitchell Crow	Editorial: Great debate Are university-based researchers about to receive a huge windfall? Or could blue-skies research - which by its very nature needs a free reign from government funders - become the next victim?
Chemistry World July 25, 2006 Bea Perks	Clinical Chaos Under Scrutiny Clinical trials of new drugs need to be tightened up, according to an expert group convened in the aftermath of UK trials that left six people fighting for their lives.
Chemistry World February 26, 2008 James Mitchell Crow	Q and A: Do Antidepressants Work? A widely-reported analysis of clinical trial data for Prozac and related antidepressant drugs has claimed that the medicines work little better than chemically-inactive placebos in all but the most severely depressed patients.
Chemistry World May 15, 2009 Katrina Megget	Tripping over red tape The UK may be moving a step closer to allowing the use of a cannabis-based drug to treat the symptoms of multiple sclerosis
Pharmaceutical Executive October 1, 2014 Leela Barham	The Gate Keeper Dr. David Haslam, Chair of the UK's National Institute of Health and Care Excellence, discusses what the quantitative calculations of value mean to patient access in today's messy world of real-time medicine.
Chemistry World May 2009	Funding fall-outs The Engineering and Physical Sciences Research Council recently announced plans to ban persistently unsuccessful grant applicants for one year. Why did it do this and why are some UK chemists unhappy about it?
Pharmaceutical Executive November 1, 2005 Sarah Houlton	Global Report: Drug Evaluation in the UK The availability of new medicines has been thrown into the limelight once more, with UK's National Institute for Health and Clinical Excellence being called upon to make dramatic improvements to the speed at which it carries out evaluations.
Chemistry World February 10, 2015 Emma Stoye	Science societies urge next UK government to invest more in research The next UK government should invest twice as much in research, according to a joint statement released by the National Academies.
Chemistry World January 28, 2013 Maria Burke	Plan for UK's 'eight great technologies' outlined Advanced materials and energy are two of the 'eight great technologies' that the UK government wants to use to propel the country to future growth.
Bio-IT World March 10, 2003 Dawn Stover	E-Recruitment: Trial by Wire Online databases are helping patients find clinical trials -- but e-recruitment is no panacea for participant shortages.
Chemistry World May 25, 2011 Sarah Houlton	Cost-cutting will stifle UK innovation The UK government's cost-cutting policies are in danger of stifling innovation, according to a report from The Work Foundation.
Chemistry World February 20, 2013 Laura Howes	UK-India projects launched To coincide with the prime minister's visit to India, UK universities have announced a series of research partnerships and scholarships intended to boost the trade and education links between the UK and India.
Chemistry World March 9, 2010 Anna Lewcock	Fund science or risk economic downfall Leading researchers and former science ministers have today warned the UK government it risks 'throwing away' years of investment unless the UK keeps pace with science funding levels in other countries.
Pharmaceutical Executive April 1, 2007 Sarah Houlton	Global Report: If It Ain't Broke Under the UK's pricing scheme, drug prices have dropped by 21% in 10 years. Is it really time for a change?
Chemistry World November 30, 2011 Patrick Walter	Autumn windfall for UK science and industry The UK government has announced a raft of measures in its autumn statement to try to boost the flagging economy. There is some good news for the research community, as well as the chemical and life science industries.
The Motley Fool June 6, 2007 Brian Orelli	Cure Your Cancer or Your Money Back Janssen-Cilag, a subsidiary of Johnson & Johnson, has recently offered to refund the cost of Velcade to the British National Health Service if the patient fails to respond to its multiple myeloma drug. Drug-company investors need not worry about these kinds of deals.
Chemistry World January 3, 2013 Sarah Houlton	2012 pharma industry roundup It may have been a relatively quiet year in terms of mergers and acquisitions, but the pharma industry nonetheless made plenty of headlines in 2012.
BusinessWeek October 14, 2010 Hutton & Penny	Britain: Sparing Health Care from Budget Cuts David Cameron's promise to increase National Health Service funding means other budget reductions will be much deeper.
Chemistry World September 7, 2012 Laura Howes	10 million open access boost UK Minister of State for Universities and Science, David Willetts, has today announced an additional investment of 10 million to help universities take up open access options.
Chemistry World June 9, 2009 Sarah Houlton	New department takes responsibility for UK science The UK government reshuffle has reunited the departments responsible for business and science.
Chemistry World September 7, 2015	Cancer Drugs Fund axes 23 treatments The Cancer Drugs Fund, which covers the cost of some cancer treatments that are not currently available on the National Health Service, has cut 23 treatments -- involving 16 drugs.
Chemistry World December 8, 2006	Expert Guidance on Clinical Trial Safety Clinical trial design in the UK is due for a shake up following the recommendations of an expert group commissioned in light of a disastrous trial that left six subjects fighting for their lives.
Chemistry World October 8, 2010 Sarah Houlton	U-turn on Alzheimer's drugs in the UK The UK National Institute for Health and Clinical Excellence proposes that those with mild disease will be able to receive them from early next year, on the basis of growing clinical evidence of their effectiveness.
Chemistry World February 7, 2013 Maria Burke	GSK commits to AllTrials data disclosure GlaxoSmithKline has become the first pharmaceutical company to sign up to a high-profile campaign to make detailed data on all clinical trials available to the public.
Chemistry World December 17, 2009 Andy Extance	STFC funding axe bodes ill for UK science The UK Science and Technology Facilities Council has announced a series of program cuts and priority shifts, indicating a direction for British research that some researchers have reacted angrily to.
Pharmaceutical Executive March 1, 2013 Ken Getz	Building Clinical Trial Awareness for Patients: Why Not Try the Pharmacist? The author explains how building a stakeholder outreach agenda around the community pharmacist can lead to a better outcome in managing the complex ins and outs of a trial protocol.
Chemistry World May 9, 2008 Richard Van Noorden	Blueprint for 1bn UK technology drive unveiled The UK's Technology Strategy Board (TSB) has outlined how it will invest 1 billion over the next three years to boost innovative R&D and business.
Chemistry World June 2009 Lord Drayson	World-leading research In the current climate - not just the downturn, but the reality of intense global competition - UK research chemists must join forces with business and government to exploit our abundant talent and potential.